NO20084189L - Proteiner, nukleinsyrer og medikamenter - Google Patents

Proteiner, nukleinsyrer og medikamenter

Info

Publication number: NO20084189L
Authority: NO; Norway
Prior art keywords: tgf; full; wild type; introduces; length wild
Prior art date: 2006-03-11

Application number

NO20084189A

Other languages

English (en)

Norwegian (no)

Inventor

Mark William James Ferguson

Hugh Gerard Laverty

Nick Occleston

Sharon O'kane

Emma Atkinson

Phillip Mellors

Original Assignee

Renovo Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-03-11

Filing date

2008-10-07

Publication date

2008-10-07

2008-10-07 Application filed by Renovo Ltd filed Critical Renovo Ltd

2008-10-07 Publication of NO20084189L publication Critical patent/NO20084189L/no

Links

239000003814 drug Substances 0.000 title abstract 2
229940079593 drug Drugs 0.000 title abstract 2
102000039446 nucleic acids Human genes 0.000 title 1
108020004707 nucleic acids Proteins 0.000 title 1
150000007523 nucleic acids Chemical class 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
102000056172 Transforming growth factor beta-3 Human genes 0.000 abstract 5
108090000097 Transforming growth factor beta-3 Proteins 0.000 abstract 5
239000012634 fragment Substances 0.000 abstract 3
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
125000000539 amino acid group Chemical group 0.000 abstract 1
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 abstract 1
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000000087 stabilizing effect Effects 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Rheumatology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

NO20084189A 2006-03-11 2008-10-07 Proteiner, nukleinsyrer og medikamenter NO20084189L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0604938.1A GB0604938D0 (en)	2006-03-11	2006-03-11	Proteins, nucleic acids and medicaments
PCT/GB2007/000833 WO2007104945A2 (en)	2006-03-11	2007-03-12	Proteins, nucleic acids and medicaments

Publications (1)

Publication Number	Publication Date
NO20084189L true NO20084189L (no)	2008-10-07

Family

ID=36241443

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20084189A NO20084189L (no)	2006-03-11	2008-10-07	Proteiner, nukleinsyrer og medikamenter

Country Status (16)

Country	Link
US (2)	US7947264B2 (pt)
EP (1)	EP2001904A2 (pt)
JP (1)	JP2009543542A (pt)
KR (1)	KR20080106450A (pt)
CN (1)	CN101437846A (pt)
AR (1)	AR063947A1 (pt)
AU (1)	AU2007226345A1 (pt)
BR (1)	BRPI0708785A2 (pt)
CA (1)	CA2645344A1 (pt)
GB (1)	GB0604938D0 (pt)
IL (1)	IL193699A0 (pt)
MX (1)	MX2008011705A (pt)
NO (1)	NO20084189L (pt)
RU (1)	RU2008140119A (pt)
SG (1)	SG170109A1 (pt)
WO (1)	WO2007104945A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0604964D0 (en)	2006-03-11	2006-04-19	Renovo Ltd	Protein folding
GB0604966D0 (en)	2006-03-11	2006-04-19	Renovo Ltd	Medicaments and proteins
GB0724203D0 (en) *	2007-12-12	2008-01-23	Renovo Ltd	Methods for the inhibition of scarring
GB0724204D0 (en) *	2007-12-12	2008-01-23	Renovo Ltd	Methods for inhibition of scarring
JP2011228644A (ja)	2010-03-29	2011-11-10	Murata Mfg Co Ltd	電子部品及びその製造方法
CN102657897A (zh) *	2012-05-21	2012-09-12	中国人民解放军第三军医大学第三附属医院	一种载TGF-β3的缓释组织工程膜的制备方法
EP3265096B9 (en)	2015-03-05	2023-10-04	TheiaNova Limited	Ophthalmic compositions and methods of use therefor

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4051848A (en)	1976-03-01	1977-10-04	Levine Norman S	Synthetic skin wound dressing
IL78197A (en)	1985-03-22	1991-07-18	Genentech Inc	Nucleic acid encoding tgf-beta and its uses
US6559123B1 (en)	1985-04-19	2003-05-06	Osi Pharmaceuticals, Inc.	Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
US5135915A (en)	1988-10-14	1992-08-04	Genentech, Inc.	Method for the treatment of grafts prior to transplantation using TGF-.beta.
CA2070393A1 (en)	1989-10-18	1991-04-19	Charles M. Cohen	Biosynthetic constructs of tgf-beta
GB8927546D0 (en)	1989-12-06	1990-02-07	Ciba Geigy	Process for the production of biologically active tgf-beta
US6054122A (en)	1990-11-27	2000-04-25	The American National Red Cross	Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9206861D0 (en)	1992-03-28	1992-05-13	Univ Manchester	Wound healing and treatment of fibrotic disorders
WO1993019783A1 (en)	1992-04-01	1993-10-14	The Whittier Institute For Diabetes And Endocrinology	Methods of inhibiting or enhancing scar formation in the cns
US5411940A (en)	1993-09-29	1995-05-02	Alcon Laboratories, Inc.	Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
US5399677A (en)	1993-12-07	1995-03-21	Genetics Institute, Inc.	Mutants of bone morphogenetic proteins
TW440566B (en)	1994-07-25	2001-06-16	Novartis Ag	Novel process for the production of biologically active dimeric protein
WO1997005166A1 (en)	1995-07-25	1997-02-13	Novartis Ag	Transforming growth factor beta crystals
DE69636739T2 (de)	1995-12-21	2007-10-18	Ajinomoto Co., Inc.	Verfahren zur rückfaltung von menschlichem activin a
CA2251129A1 (en)	1996-05-03	1997-11-13	Innogenetics N.V.	New medicaments containing gelatin cross-linked with oxidized polysaccharides
EP1074620A1 (en)	1999-08-06	2001-02-07	HyGene AG	Monomeric protein of the TGF-beta family
US20020052026A1 (en)	1997-10-08	2002-05-02	Steven M. Vicik	Methods of refolding proteins
US5972321A (en) *	1998-06-30	1999-10-26	Akpharma Inc.	Acid neutralization of skin
BR9915919A (pt)	1998-10-07	2001-08-21	Syngenta Participations Ag	Proteìnas terapeuticamente ativas em plantas
US6677432B1 (en) *	1998-10-07	2004-01-13	Stryker Corporation	Mutations of the C-terminal portion of TGF-β superfamily proteins
JP2002539172A (ja)	1999-03-17	2002-11-19	ノバルティスアクチエンゲゼルシャフト	Ｔｇｆ−ベータを含む医薬組成物
WO2000056879A1 (en)	1999-03-22	2000-09-28	Universität Zürich	TRANSFORMING GROWTH FACTOR (TFG) β SUPERFAMILY ANTAGONISTS
AR027765A1 (es)	2000-04-03	2003-04-09	Monsanto Technology Llc	Expresion y purificacion de polipeptidos bioactivos autenticos a partir de plantas
EP1616875A1 (en)	2000-04-25	2006-01-18	Otsuka Pharmaceutical Co., Ltd.	GD3-mimetic peptides
US20040078851A1 (en)	2000-05-02	2004-04-22	Ning Huang	Production of human growth factors in monocot seeds
DE10026713A1 (de) *	2000-05-30	2001-12-06	Walter Sebald	Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
WO2002012336A2 (en)	2000-08-09	2002-02-14	Curis, Inc.	TGF-β THERAPEUTICS, COMPOSITIONS AND METHODS OF USE
AU2002257703A1 (en)	2001-03-23	2002-10-08	Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh	Use of cytokines of the tgf-beta superfamily for the treatment and diagnosis of skin related disorders
US20030033637A1 (en)	2001-06-05	2003-02-13	Croptech Corporation	Gene expression and production of TGF-beta proteins including bioactive mullerian inhibiting substance from plants
WO2004029256A2 (es)	2002-09-27	2004-04-08	Centro De Ingenieria Genetica Y Biotecnologia	Vector para la producción de plantas angiospermas transplastómicas
CA2577690C (en)	2004-08-19	2013-08-06	Biogen Idec Ma Inc.	Refolding transforming growth factor beta family proteins
US20060162026A1 (en)	2004-12-23	2006-07-20	Karen Oishi	Expressing TGF-beta proteins in plant plastids
JP2009501200A (ja)	2005-07-12	2009-01-15	レノボ・リミテッド	ＴＧＦ−βスーパーファミリーメンバーを含有する医薬組成物
GB0514262D0 (en)	2005-07-12	2005-08-17	Renovo Ltd	Promotion of epithelial regeneration
GB0604964D0 (en)	2006-03-11	2006-04-19	Renovo Ltd	Protein folding
GB0604966D0 (en)	2006-03-11	2006-04-19	Renovo Ltd	Medicaments and proteins
GB0617816D0 (en)	2006-09-11	2006-10-18	Renovo Ltd	Nucleic acids and methods of protein expression

2006
- 2006-03-11 GB GBGB0604938.1A patent/GB0604938D0/en not_active Ceased
2007
- 2007-03-12 CA CA002645344A patent/CA2645344A1/en not_active Abandoned
- 2007-03-12 KR KR1020087023406A patent/KR20080106450A/ko not_active Withdrawn
- 2007-03-12 WO PCT/GB2007/000833 patent/WO2007104945A2/en not_active Ceased
- 2007-03-12 CN CNA2007800163435A patent/CN101437846A/zh active Pending
- 2007-03-12 AU AU2007226345A patent/AU2007226345A1/en not_active Abandoned
- 2007-03-12 EP EP07712874A patent/EP2001904A2/en not_active Withdrawn
- 2007-03-12 SG SG201101795-1A patent/SG170109A1/en unknown
- 2007-03-12 JP JP2008558882A patent/JP2009543542A/ja active Pending
- 2007-03-12 RU RU2008140119/13A patent/RU2008140119A/ru not_active Application Discontinuation
- 2007-03-12 US US12/282,463 patent/US7947264B2/en not_active Expired - Fee Related
- 2007-03-12 BR BRPI0708785-3A patent/BRPI0708785A2/pt not_active IP Right Cessation
- 2007-03-12 MX MX2008011705A patent/MX2008011705A/es unknown
- 2007-09-12 AR ARP070104046A patent/AR063947A1/es not_active Application Discontinuation
2008
- 2008-08-26 IL IL193699A patent/IL193699A0/en unknown
- 2008-10-07 NO NO20084189A patent/NO20084189L/no not_active Application Discontinuation
2011
- 2011-01-11 US US13/004,589 patent/US20110105396A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20110105396A1 (en)	2011-05-05
MX2008011705A (es)	2008-09-26
IL193699A0 (en)	2011-08-01
AU2007226345A1 (en)	2007-09-20
WO2007104945A2 (en)	2007-09-20
JP2009543542A (ja)	2009-12-10
RU2008140119A (ru)	2010-04-20
KR20080106450A (ko)	2008-12-05
GB0604938D0 (en)	2006-04-19
AR063947A1 (es)	2009-03-04
SG170109A1 (en)	2011-04-29
WO2007104945A3 (en)	2008-05-15
EP2001904A2 (en)	2008-12-17
CN101437846A (zh)	2009-05-20
BRPI0708785A2 (pt)	2011-06-14
US7947264B2 (en)	2011-05-24
CA2645344A1 (en)	2007-09-20
US20090105146A1 (en)	2009-04-23

Legal Events

Date	Code	Title	Description
2012-10-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20084189L (no)	2008-10-07	Proteiner, nukleinsyrer og medikamenter
Thompson et al.	2013	Chemoselective peptide ligation-desulfurization at aspartate.
BRPI0515649B8 (pt)	2021-11-03	Processo para preparação de composições de anticorpo monoclonal altamente concentradas
NO20092774L (no)	2009-07-27	HLA-A*1101-begrenset WT1-peptid og farmasoytisk preparat som omfatter dette
WO2009108261A3 (en)	2010-01-28	Compositions and methods for the treatment of viral infections
ES2353814T3 (es)	2011-03-07	Proteinas n-glicosiladas recombinantes de celulas procariotas.
NO20091563L (no)	2009-04-20	Proteaseresistente insulinanaloger
NO20092697L (no)	2009-09-28	Transportmolekyler ved bruk av revers-sekvens HIV-TAT polypeptider
ATE376591T1 (de)	2007-11-15	Neisseria meningitidis antigene und zusammenstellungen
MX2009013635A (es)	2010-05-19	Composiciones que inhiben la influenza y metodos.
EP1801206A4 (en)	2009-01-14	PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE
BR112014013367A2 (pt)	2017-06-13	polipeptídeo
DK1507002T3 (da)	2007-04-10	Termostabilt Taq-polymerasefragment
EP1915390A4 (en)	2009-06-03	COMPOSITIONS AND METHODS FOR MONITORING AND MODIFYING PROTEIN FOLDING AND SOLUBILITY
WO2007089038A8 (ja)	2008-05-15	新規ホスホリパーゼｄ
DE602004031642D1 (de)	2011-04-14	Methode zur verbesserung der wirksamkeit von biologischen antwort-verändernden proteinen und exemplarische muteine
WO2010007144A3 (en)	2010-03-11	Mutated netrin-4 proteins, fragments thereof and their uses as drugs
AU2016277449B2 (en)	2019-06-20	Protease-resistant lipidated GLP-1 analogs
IL175319A (en)	2013-07-31	Phosphorus-related protein, preparations containing @ the same L @ use @ it @ and method @ to identify it
DE60319369D1 (de)	2008-04-10	Nukleinsäuren, polypeptide und verfahren zur modulierung von apoptosis
DK1904529T3 (da)	2010-11-15	Anvendelse af Stefin A som et scaffoldprotein
SE0302559D0 (sv)	2003-09-25	Method
DK2173371T3 (da)	2012-02-06	Peptider afledt af plasminogenaktivatorinhibitor-1 og anvendelser deraf
ATE549346T1 (de)	2012-03-15	Chemische modifikation von proteinen
PT2289533E (pt)	2013-12-10	Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos